Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03649659 · ClinicalTrials.gov registry record · Phase 3
Effectiveness of Silver Diamine Fluoride (SDF) in Arresting Cavitated Caries Lesions
A Phase 3 study, sponsored by University of Michigan.
- Terminated
- Registry status
- Phase 3
- Development phase
- 830
- Enrollment target
NCT03649659 is a Phase 3 study that was terminated before completion, run by University of Michigan. The registered enrollment target is 830 participants.
The verdict
NCT03649659, a Phase 3 study, was terminated before completion, sponsored by University of Michigan.
- TERMINATED
- Registry status
- Phase 3
- Development phase
- 830 participants
- Enrollment target
Study Summary
This trial is a Phase III, multisite, randomized, placebo-controlled trial, with two parallel groups. The groups are SDF or placebo and they are applied every 6 months. The primary hypothesis of the trial is that SDF is better than placebo for stopping cavities with dentin exposed in baby teeth when assessed at 6 months after initial application.
Interventions
- DRUG Placebo
- DRUG Silver Diamine Fluoride
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 830 participants |
| Start Date | 2018-10-08 |
| Est. Completion | 2023-04-27 |
| Phase | Phase 3 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03649659
The ClinicalTrials.gov registry entry for NCT03649659 describes a study currently listed as terminated, categorized as Phase 3. The registered enrollment target is 830 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Michigan, which has 1,327 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Placebo is the first listed.
NCT03649659 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT03649659 about?
NCT03649659 is a clinical study titled "Effectiveness of Silver Diamine Fluoride (SDF) in Arresting Cavitated Caries Lesions". This trial is a Phase III, multisite, randomized, placebo-controlled trial, with two parallel groups. The groups are SDF or placebo and they are applied every 6 months. The primary hypothesis of the trial is that SDF is better than placebo for stopping cavities with dentin exposed in baby teeth when...
What is the current status of trial NCT03649659?
This trial is currently terminated. It is a Phase 3 study. The enrollment target is 830 participants. The study started on 2018-10-08. Estimated completion is 2023-04-27.
What interventions are being tested in trial NCT03649659?
The interventions under investigation include: Placebo (DRUG), Silver Diamine Fluoride (DRUG).
Who is sponsoring clinical trial NCT03649659?
This trial is sponsored by University of Michigan, which has 1,327 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.